These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 24042299)

  • 1. [Does budget consequences control Norwegian reimbursement priorities?].
    Robberstad B; Askildsen JE; Norheim OF
    Tidsskr Nor Laegeforen; 2013 Sep; 133(17):1841-3. PubMed ID: 24042299
    [No Abstract]   [Full Text] [Related]  

  • 2. Value in Health: How It Is Defined and Used in Priority Setting and Pricing in Norway.
    Melberg HO
    Healthc Pap; 2019 Oct; 18(3):22-28. PubMed ID: 31642804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Priorisation in health-care; drug-reimbursement priorities in Hungary in 2004].
    Kárpati K; Brandtmüller A; Májer I; Gulácsi L
    Acta Pharm Hung; 2006; 76(4):191-9. PubMed ID: 17575799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Priority-setting criteria in the Norwegian health services.
    Wisløff T
    Tidsskr Nor Laegeforen; 2015 Aug; 135(15):1373-5. PubMed ID: 26315241
    [No Abstract]   [Full Text] [Related]  

  • 5. Medicare, the bell rings; Title XIX... nine more state plans approved.
    Callahan B
    Hosp Prog; 1966 Jul; 47(7):87-102. PubMed ID: 15861576
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmaceutical pricing and reimbursement reforms in Greece.
    Yfantopoulos J
    Eur J Health Econ; 2008 Feb; 9(1):87-97. PubMed ID: 17619920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug reimbursement policies in Canada--need for improved access to critical therapies.
    LeLorier J; Bell A; Bougher DJ; Cox JL; Turpie AG
    Ann Pharmacother; 2008 Jun; 42(6):869-73. PubMed ID: 18477735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biased criticism of drug reimbursement rules].
    Lindberg M
    Ugeskr Laeger; 2008 Apr; 170(15):1261; author reply 1261. PubMed ID: 18472464
    [No Abstract]   [Full Text] [Related]  

  • 9. Industry ponders reimbursement crisis.
    Bouchie A
    Nat Biotechnol; 2003 Apr; 21(4):347-8. PubMed ID: 12665810
    [No Abstract]   [Full Text] [Related]  

  • 10. A survey of reimbursement practices of private health insurance companies for pharmaceuticals not covered under the Pharmaceutical Benefits Scheme 2008.
    Lingaratnam SM; Kirsa SW; Mellor JD; Jackson J; Crellin W; Fitzsimons M; Zalcberg JR
    Aust Health Rev; 2011 May; 35(2):204-10. PubMed ID: 21612735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Economic feasibility study and reimbursement rules--illustrated by a concrete example].
    Kolenda K; Friis ML
    Ugeskr Laeger; 2008 Apr; 170(15):1257; author reply 1257. PubMed ID: 18472461
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influence of the reimbursement scheme on the consumption of drugs].
    Madsen UK
    Ugeskr Laeger; 2009 Mar; 171(10):783-6. PubMed ID: 19265600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Priorities for health services research in primary care.
    Schäfer W; Groenewegen PP; Hansen J; Black N
    Qual Prim Care; 2011; 19(2):77-83. PubMed ID: 21575330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The "Health Benefit Basket" in Denmark: a description of entitlements, actors, and decision-making processes in the curative health sector.
    Bilde L; Ankjaer-Jensen A; Danneskiold-Samsøe B
    Eur J Health Econ; 2005 Dec; Suppl(Suppl 1):11-7. PubMed ID: 16270211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health research in Africa: getting priorities right.
    Olesen OF; Parker MI
    Trop Med Int Health; 2012 Sep; 17(9):1048-52. PubMed ID: 22716126
    [No Abstract]   [Full Text] [Related]  

  • 16. Finance fibrillation and research rhythm: do we need a pacemaker?
    Apolone G; Patarnello F
    J Ambul Care Manage; 2008; 31(2):187-9. PubMed ID: 18360180
    [No Abstract]   [Full Text] [Related]  

  • 17. Medicare and drug pricing.
    Iglehart JK
    N Engl J Med; 2003 Apr; 348(16):1590-7. PubMed ID: 12700381
    [No Abstract]   [Full Text] [Related]  

  • 18. [Physicians' experience with increased use of individual reimbursement for pharmaceuticals].
    Levorsen A; Kristiansen IS; Aasland OG
    Tidsskr Nor Laegeforen; 2008 Aug; 128(16):1829-32. PubMed ID: 18787593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reimbursement systems, organisational forms and patient selection: evidence from day surgery in Norway.
    Martinussen PE; Hagen TP
    Health Econ Policy Law; 2009 Apr; 4(Pt 2):139-58. PubMed ID: 19239728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Close to a bull's eye--a concurring opinion.
    Weil TP
    Health Care Manage Rev; 1995; 20(2):35-44. PubMed ID: 7607883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.